No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

IAI Announces Medical Assist ELECYLINDER Series

Editor: What To Know

  • Built on “Quality and Innovation,” IAI is a leader in the research and development of advanced energy-efficient and affordable Cartesian, SCARA, and Tabletop robots.
  • “IAI is proud to be in the forefront of technology to assist the medical community in the battle against Covid-19 and any future health crisis,”.
  • Here is an example of how an ELECYLINDER Series was used to improve a face mask manufacturing process.

February 1, 2021

ELECYLINDER, IAI

IAI (Intelligent Actuator Incorporated), a leading robotics provider headquartered in Shizuoka, Japan,­­ would like to introduce their ELECYLINDER®  Series.

Introducing the ELECYLINDER electric actuator developed by IAI. The main features are easy operation, AVD (acceleration / speed / deceleration) that can be adjusted individually, and high performance. Due to its stable quality, it is ideal for the manufacturing industry of medical products where product accuracy is required.

Here is an example of how an ELECYLINDER Series was used to improve a face mask manufacturing process. While using a conventional air cylinder to cut mask connection parts, stoppers gradually worn down. This caused cutting positions to shift, which led to defective products and production had to stop. Implementing the ELECYLINDER eliminated damaged stopper parts, production continued, and productivity got a boost.

“IAI is proud to be in the forefront of technology to assist the medical community in the battle against Covid-19 and any future health crisis,” says Kaz Haruna, National Sales Manager for IAI America. The current pandemic creates an urgent need for readily available multiple testing and diagnostic tools worldwide.

IAI is actively assisting the medical community by providing Cartesian and SCARA robots for infectious disease testing, molecular diagnostics, tissue and blood sampling, genomic research, cancer research, pharmaceuticals, and medical device production. It is IAI’s hope that our ELECYLINDER Series will help the medical/pharmaceutical industries move ahead with advanced innovation.

About IAI: Founded in Shimizu, Japan in 1976, Intelligent Actuator Incorporated (IAI) has over forty years of experience in the design and manufacture of customized medical and industrial robotics. Built on “Quality and Innovation,” IAI is a leader in the research and development of advanced energy-efficient and affordable Cartesian, SCARA, and Tabletop robots. From entry-level to high-speed models, IAI provides complete programmable systems and components to fulfill any and all of your medical testing and industrial production needs.

IAI Map Location

 

 

 

 

 

 

★ USA Headquarters & Western Region
2690 West 237 Street, Torrance, CA 90505
(310) 891-6015

★ Midwest Branch Office
110 East State Parkway, Schaumburg, IL 60173
(847) 908-1400

★ Southern Branch Office
1220 Kennestone Circle, Suite 108
Marietta, GA 30066(678) 354-9470

★ Japan Headquarters
577-1 Obane, Shimizu-ward
Shizuoka-city, Shizuoka-pref.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy